About this trial
The goal of this intervention study is to determine the effect of a tailored exercise program (with aerobic, strength and balance training) in patients with FSHD.
The main aim is to determine the effect of the exercise program on pain and fatigue.
Participants will follow a 16 week training program with tailored exercises. The exercises will be prescribed via the app 'Physitrack'. After 16 weeks, the effect on pain, fatigue, fatigability, aerobic capacity, balance, physical function, sleep and the ability to participate in social activities will be determined.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Age >18 years
Verified diagnosis of FSHD type 1, based on the clinical criteria established by Padberg et al. (1991) (22).
Category A or B of the four clinical categories according to the Comprehensive Clinical Evaluation Form (23), these patients have the most peculiar signs of the disease
A CIS-fatigue score of ≥ 35
Disqualifiers
Use of beta-blocker medication
Presence of additional diseases likely to interfere with the measurements
Psychological-psychiatric disorders
A musculoskeletal injury that impairs exercising
Trial design
Sequential
Treatments tested in this trial
Personalised Exercise
BehavioralAn individualized exercise program consisting of aerobic exercises, strength exercises and balance exercises. The exercises will be prescribed via the Physitrack app.
Historical control group
BehavioralAerobic training (see study Voet 2024, Both aerobic exercise and cognitive-behavioral therapy reduce chronic fatigue in FSHD)
Treatment groups
Trial outcomes
Primary outcomes
Daily observed pain
Daily observed pain during a period of 2 weeks, measured with the Visual Analog Scale (VAS)
Fatigue
The chronic fatigue score assessed using the Checklist Individual Strength (CIS-fatigue) fatigue subscale.
Secondary outcomes
Performance fatigability
The quadriceps isometric intermittent fatigue test (QIF test)
Fatigue (VAS)
VAS fatigue
Aerobic capacity
B-FIT Exercise test
Long function
Maximal expiratory pressure (MEP)
Locations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Radboud University Medical Center
Lead sponsor
Università di Pavia
Collaborator
This trial is not recruiting at the moment. You can still explore other options: